379 related articles for article (PubMed ID: 32237509)
1. [Effect of nanostructured lipid carriers (NLCs) in improving stability of essential oils and its application].
Li Y; Wu ZF; Kuang WW; Li YH; Chen BY; Yang M
Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(3):523-530. PubMed ID: 32237509
[TBL] [Abstract][Full Text] [Related]
2. Nanostructured Lipid Carriers (NLCs) for Drug Delivery: Role of Liquid Lipid (Oil).
D'Souza A; Shegokar R
Curr Drug Deliv; 2021; 18(3):249-270. PubMed ID: 32324512
[TBL] [Abstract][Full Text] [Related]
3. Distribution of a model bioactive within solid lipid nanoparticles and nanostructured lipid carriers influences its loading efficiency and oxidative stability.
Pan Y; Tikekar RV; Nitin N
Int J Pharm; 2016 Sep; 511(1):322-330. PubMed ID: 27418566
[TBL] [Abstract][Full Text] [Related]
4. Riluzole-Loaded Nanostructured Lipid Carriers for Hyperproliferative Skin Diseases.
Llorente X; Esteruelas G; Bonilla L; Agudelo MG; Filgaira I; Lopez-Ramajo D; Gong RC; Soler C; Espina M; García ML; Manils J; Pujol M; Sánchez-López E
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175765
[TBL] [Abstract][Full Text] [Related]
5. The effect of surfactant composition on the chemical and structural properties of nanostructured lipid carriers.
Karn-Orachai K; Smith SM; Phunpee S; Treethong A; Puttipipatkhachorn S; Pratontep S; Ruktanonchai UR
J Microencapsul; 2014; 31(6):609-18. PubMed ID: 24861323
[TBL] [Abstract][Full Text] [Related]
6. Nanostructured lipid carriers for the topical delivery of tretinoin.
Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N
Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial Activity of Nanostructured Lipid Carriers Loaded
Fathi N; Lotfipour F; Dizaj SM; Hamishehkar H; Mohammadi M
Pharm Nanotechnol; 2020; 8(6):485-494. PubMed ID: 33407060
[TBL] [Abstract][Full Text] [Related]
8. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application.
Naseri N; Valizadeh H; Zakeri-Milani P
Adv Pharm Bull; 2015 Sep; 5(3):305-13. PubMed ID: 26504751
[TBL] [Abstract][Full Text] [Related]
9. Protection and viability of fruit seeds oils by nanostructured lipid carrier (NLC) nanosuspensions.
Krasodomska O; Paolicelli P; Cesa S; Casadei MA; Jungnickel C
J Colloid Interface Sci; 2016 Oct; 479():25-33. PubMed ID: 27348480
[TBL] [Abstract][Full Text] [Related]
10. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
[TBL] [Abstract][Full Text] [Related]
11. Methods for preparation of nanostructured lipid carriers.
Gomaa E; Fathi HA; Eissa NG; Elsabahy M
Methods; 2022 Mar; 199():3-8. PubMed ID: 33992771
[TBL] [Abstract][Full Text] [Related]
12. Natural Lipids as Structural Components of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Topical Delivery.
Dobreva M; Stefanov S; Andonova V
Curr Pharm Des; 2020; 26(36):4524-4535. PubMed ID: 32410552
[TBL] [Abstract][Full Text] [Related]
13. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
Li H; Chen M; Su Z; Sun M; Ping Q
Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
[TBL] [Abstract][Full Text] [Related]
14. Nanostructured lipid carriers and their current application in targeted drug delivery.
Jaiswal P; Gidwani B; Vyas A
Artif Cells Nanomed Biotechnol; 2016; 44(1):27-40. PubMed ID: 24813223
[TBL] [Abstract][Full Text] [Related]
15. Lipid-Based Nanostructures for the Delivery of Natural Antimicrobials.
Pinilla CMB; Lopes NA; Brandelli A
Molecules; 2021 Jun; 26(12):. PubMed ID: 34208209
[TBL] [Abstract][Full Text] [Related]
16. Design of Quercetin-Loaded Natural Oil-Based Nanostructured Lipid Carriers for the Treatment of Bacterial Skin Infections.
de Barros DPC; Santos R; Reed P; Fonseca LP; Oliva A
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557947
[TBL] [Abstract][Full Text] [Related]
17. Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers.
Negi LM; Jaggi M; Talegaonkar S
Int J Pharm; 2014 Jan; 461(1-2):403-10. PubMed ID: 24345574
[TBL] [Abstract][Full Text] [Related]
18. Effect of Oil Content on Physiochemical Characteristics of γ-Oryzanol-Loaded Nanostructured Lipid Carriers.
Pornputtapitak W; Pantakitcharoenkul J; Teeranachaideekul V; Sinthiptharakoon K; Sapcharoenkun C; Meemuk B
J Oleo Sci; 2019 Aug; 68(8):699-707. PubMed ID: 31292337
[TBL] [Abstract][Full Text] [Related]
19. Developed and characterization of nanostructured lipid carriers containing food-grade interesterified lipid phase for food application.
da Silva MG; de Godoi KRR; Gigante ML; Pavie Cardoso L; Paula Badan Ribeiro A
Food Res Int; 2022 May; 155():111119. PubMed ID: 35400405
[TBL] [Abstract][Full Text] [Related]
20. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]